Hugo Sigman Contents Biographical data and experience Life Sciences Agribusiness Communication and Art Social Responsibility: Mundo Sano Foundation International Awards and Accolades References External links Navigation menuhugosigman.comEY"Las 50 personas más ricas de la Argentina según la revista Forbes"Utrecht University. Cooperation for affordable medicines in developing countriesPrimera firma extranjera dedicada a producir vacunas en china10.1002/pbc.2563126154941"Antibodies to watch in 2015"10.4161/19420862.2015.98894446229672548405510.1586/14760584.2015.9846912542089710.1358/dot.2014.50.4.211667024918647Satirical ‘Wild Tales’ stands out among Oscar’s foreign language nominees"Damian Szifron lives his own wild tale"Interview with Ricardo Darin, Variety LatinoGoing wild at the Argentinean box officeSociedad Central de ArquitectosChagas disease - inheriting a silent killerFrom Salta to Ethiopia: Mundo Sano replicates its original work in the fight against soil-transmitted helminthsGlobal Partners Are Taking the "Neglect" out of "Neglected Tropical Diseases"Hugo Sigman, Entrepreneur of the YearProgramme of meetings, april 2012, Journal UNCTAD XIII, Doha, QatarOfficial websiteGrupo InsudChemo GroupExeltismAbxienceKramer & Sigman FilmsEditorial Capital intelectualPomera MaderasGarruchosSolantuYacaré PoráPuerto Valle - Hotel de EsterosMundo SanoResearch, Development and Innovation ConsortiumArgentine Chamber of Biotechnologyno20081329243181862231818622

1944 birthsArgentine businesspeopleArgentine psychiatristsArgentine pharmacistsArgentine scientistsArgentine JewsArgentine people of German-Jewish descentUniversity of Buenos Aires alumniLiving people


Grupo InsudArgentinaUniversidad de Buenos AiresDr. Pichon RiviéreSpainWorld Health OrganizationUtrecht Universitymonoclonal antibodyRacotumomabUniversidad Nacional de QuilmesUniversidad Nacional de San MartínGarrahanAcademia Nacional de MedicinabiotechnologyOscar KramerEl DeseoPedro AlmodóvarAgustín AlmodóvarDamián SzifronRicardo DarínDarío GrandinettiÉrica RivasOscar MartínezLeonardo SbaragliaMuseo Reina Sofíaneglected tropical diseasesChagasdenguesoil-transmitted helminthsEntrepreneur of the Year AwardEYEndeavorKonex AwardsUnited NationsQatarUnited Nations Conference on Trade and DevelopmentGenevaSwitzerlandArgentine Industrial UnionHarvardColumbia














Hugo Sigman
Hugo-sigman.png
Born1944

Buenos Aires, Argentina

OccupationCEO of Grupo Insud
Net worth
IncreaseUS$1.6 billion (June 2018, jointly with wife)[1]
Spouse(s)Silvia Gold
Websitehugosigman.com

Hugo Sigman is the founder, CEO and –jointly with his wife, Biochemist Silvia Gold— the only shareholder of Grupo Insud, a business conglomerate with an active presence in the fields of pharmaceuticals, agroforestry, culture, nature and design.




Contents





  • 1 Biographical data and experience


  • 2 Life Sciences


  • 3 Agribusiness


  • 4 Communication and Art

    • 4.1 Wild tales



  • 5 Social Responsibility: Mundo Sano Foundation


  • 6 International Awards and Accolades


  • 7 References


  • 8 External links




Biographical data and experience


Hugo Sigman was born in Buenos Aires, Argentina, in 1944. He completed his primary and secondary schooling in public schools.
In 1969, he earned his Medical Doctor degree from Universidad de Buenos Aires, and in the same year, he graduated from the Social Psychology School led by Dr. Pichon Riviére.


In 1970, he joined as Resident the Psychiatry Service of Policlínico Lanús, directed by Professor Mauricio Goldenberg. He continued his career, first as Chief of Residents, and then as founder and director of the Psychiatric Emergency Unit at the same hospital. In 1976, he moved to Spain, where he worked at the Psychiatry Service of Hospital Clínico de Barcelona.


At that time, encouraged by his father-in-law Roberto Gold, Hugo Sigman started his entrepreneurial career and got involved in the pharmaceutical industry.
In 1978, with his wife, Silvia Gold –his partner in love and work for 45 years-, he founded Chemo, a chemical-pharmaceutical company, and the first company of Grupo Insud.
Their goal was to create a company to produce high-quality medicines at affordable prices.
In the 1980s, Hugo and Silvia returned to Argentina to continue the path they had started in Europe.



Life Sciences


At present, Grupo Insud comprises three companies in the life sciences industry: Chemo, a company that sells active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) to 1,200 pharmaceutical companies around the world, has 15 manufacturing sites and 9 R&D centers; Exeltis, a company that sells branded products in more than 40 countries, and mAbxience, a biotech company created in 2008, with 3 manufacturing sites, the first monoclonal antibody plant in Latin America –pharmADN- and the first vaccine and biotech production plant in Argentina, Sinergium Biotech.


Chemo signed an agreement with the World Health Organization and Utrecht University to produce the Palivizumab monoclonal antibody and facilitate access to this medicine for premature children, as it is estimated that 250,000 premature children die every year around the world without treatment due to its high cost.[2]


Jointly with renowned Argentine companies, in 2011 Hugo Sigman founded the Argentine Chamber of Biotechnology, Cámara Argentina de Biotecnología, which he currently chairs. The goal of CAB is to strengthen the public-private collaboration policy in biotechnology and encourage its development in the region.
In Argentina's veterinary industry, he is a partner of Biogénesis Bagó, which runs a world-class facility for foot-and-mouth disease vaccine production, the only one that has been authorized by the government of China to build a plant in that country.[3]


For 20 years, Hugo and Silvia have led the Public-Private Consortium for Research and Development of Innovative Oncology Therapies, which developed the first therapeutic vaccine against lung cancer, Racotumomab (Vaxira),[4][5][6][7] introduced in 2013, and which currently has five new products in research.


In this framework, Hugo Sigman strongly supports public-private partnerships, which he views as a positive paradigm to be promoted with ethics and transparency. He understands that public research centers should give back to society by contributing their knowledge and developments, and the private sector should recognize that contribution by compensating them accordingly. Inspired in that model, he has built partnerships with prestigious institutions including Universidad de Buenos Aires, Universidad Nacional de Quilmes, Universidad Nacional de San Martín, Roffo and Garrahan Hospitals, Academia Nacional de Medicina, and several foreign universities.


Approximately 250 researchers work at the partnerships supported by the Group, doing basic and applied research; 100 of them are dedicated to the development of products for treating cancer.



Agribusiness


His entrepreneurial spirit and interest in biology have led Hugo Sigman beyond the frontiers of the pharmaceutical industry. In 1998, he started agricultural and forestry activities in different locations of Argentina, focused on genetic improvement and sustainable production, with companies Garruchos, devoted to farming and cattle-raising; Pomera, ranked as the top Argentine-capital forestry company; and Cabaña Los Murmullos, a leading cattle breeding ranch.
Sigman is also a shareholder of Bioceres, an Argentine biotechnology company focused on agricultural production. This young company developed a gene that enables the production of wheat, corn and soybean resistant to draughts and soil salinity, and has licensed its products to the USA, France and India.



Communication and Art


Hugo Sigman encourages the exchange of ideas through publishing company Capital intellectual, which includes a line of publications in Spain under the publishing brand Clave Intellectual, the Southern Cone edition of Le Monde Diplomatique, and the Latin American version of prestigious The New York Review of Books.
In 2005, Hugo Sigman partnered with Oscar Kramer and established filmmaking company Kramer&Sigman Films (K&S), which has grown to be a thriving production company, with several box-office successes, including Kamchatka, El perro, The Last Elvis, Seventh Floor, Wild Tales.[8]



Wild tales


Produced by Hugo Sigman for Kramer& Sigman Films and by El Deseo (Pedro Almodóvar and Agustín Almodóvar ’s production company), Wild Tales (Relatos Salvajes) was directed by Damián Szifron,[9] starring Ricardo Darín,[10] Julieta Zylberberg, Rita Cortese; Darío Grandinetti; Érica Rivas; Oscar Martínez and Leonardo Sbaraglia. Co-produced by Telefé and Corner, and distributed by Warner Bros. Pictures, Wild Tales exceeded 1 million tickets sold in its first ten days of screening.[11]


An art and culture enthusiast, between 2010 and 2013, Hugo Sigman was a member of the Advisory Council of the [[National Fine Arts Museum of
Argentina]], and is currently a member of the Board of Patronage of Museo Reina Sofía, in Madrid, Spain. Additionally, the venue of Grupo INSUD in Buenos Aires (the traditional Díaz Vélez Palace), built in 1907 and recently restored, has won several architectural awards and has been declared a protected heritage site of Buenos Aires City.[12]



Social Responsibility: Mundo Sano Foundation


Hugo and Silvia have always had a strong commitment to give back to society. This social responsibility is infused in their work with the Mundo Sano Foundation.[13] in Argentina, Spain and Ethiopia,[14] with the vision to transform the reality of populations affected by neglected tropical diseases (NTDs) including Chagas, dengue and soil-transmitted helminths.[15]



International Awards and Accolades


In 2015, Hugo Sigman received the Entrepreneur of the Year Award, from EY consulting firm (Ernst & Young) in Argentina.[16]


In 2013, the Endeavor Foundation named him the "Model Entrepreneur" for his values and track record. In 2008, he received the merit diploma at the Konex Awards, in the "Innovative Entrepreneurs" category. In 2011, jointly with Silvia Gold, he received an award from Asociación de Dirigentes de Empresa (ADE) in the "Agroindustry" category.


Sigman presented the achievements of the Research, Development and Innovation Consortium at Experience Endeavor in August 2013, and at the 11th International Symposium on AIDS, organized by Fundación Huésped, in 2012.


In April 2012, he was a speaker at the Global Investment Forum, organized by the United Nations in Qatar.[17] He presented the state-of-the-art productive investment model based on partnerships with other pharmaceutical companies and public entities.


In September 2011, Sigman was guest speaker at the United Nations Conference on Trade and Development held in Geneva, Switzerland. His lecture was about the manufacturing of vaccines and biotechnologicals in Argentina. The Sinergium Biotech model of integration for the production of vaccines and biotech products involves technology transfer, export potential and the creation of 320 jobs, said Sigman. Also in 2011, Sigman delivered a presentation on global entrepreneurship at the 47th IDEA Colloquium.


In 2009, Sigman took part in the 15th Conference of the Argentine Industrial Union, and was guest speaker representing Argentina at Harvard and Columbia Universities.



References




  1. ^ "Las 50 personas más ricas de la Argentina según la revista Forbes". infobae.com. Retrieved 5 November 2018..mw-parser-output cite.citationfont-style:inherit.mw-parser-output .citation qquotes:"""""""'""'".mw-parser-output .citation .cs1-lock-free abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .citation .cs1-lock-subscription abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:help.mw-parser-output .cs1-ws-icon abackground:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center.mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:inherit;padding:inherit.mw-parser-output .cs1-hidden-errordisplay:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-maintdisplay:none;color:#33aa33;margin-left:0.3em.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em


  2. ^ Utrecht University. Cooperation for affordable medicines in developing countries


  3. ^ Primera firma extranjera dedicada a producir vacunas en china


  4. ^ Cacciavillano, W; Sampor, C; Venier, C; Gabri, MR; de Dávila, MT; Galluzzo, ML; Guthmann, MD; Fainboim, L; Alonso, DF; Chantada, GL (Jul 2015). "A phase I study of the anti-idiotype vaccine racotumomab in neuroblastoma and other pediatric refractory malignancies". Pediatr Blood Cancer. 62: 2120–4. doi:10.1002/pbc.25631. PMID 26154941.


  5. ^ Reichert, JM (2015). "Antibodies to watch in 2015". MAbs. 7 (1): 1–8. doi:10.4161/19420862.2015.988944. PMC 4622967. PMID 25484055.


  6. ^ Hernández, AM; Vázquez, AM (Jan 2015). "Racotumomab-alum vaccine for the treatment of non-small-cell lung cancer". Expert Rev Vaccines. 14 (1): 9–20. doi:10.1586/14760584.2015.984691. PMID 25420897.


  7. ^ Gajdosik, Z (Apr 2014). "Racotumomab - a novel anti-idiotype monoclonal antibody vaccine for the treatment of cancer". Drugs Today (Barc). 50 (4): 301–7. doi:10.1358/dot.2014.50.4.2116670. PMID 24918647.


  8. ^ Satirical ‘Wild Tales’ stands out among Oscar’s foreign language nominees Washington Post.


  9. ^ Sigal Ratner-Arias (January 16, 2015). "Damian Szifron lives his own wild tale". AP.


  10. ^ Interview with Ricardo Darin, Variety Latino


  11. ^ Going wild at the Argentinean box office El País


  12. ^ Sociedad Central de Arquitectos


  13. ^ Chagas disease - inheriting a silent killer BBC


  14. ^ From Salta to Ethiopia: Mundo Sano replicates its original work in the fight against soil-transmitted helminths


  15. ^ Global Partners Are Taking the "Neglect" out of "Neglected Tropical Diseases" Bill and Melinda Gates Foundation


  16. ^ Hugo Sigman, Entrepreneur of the Year Clarín


  17. ^ Programme of meetings, april 2012, Journal UNCTAD XIII, Doha, Qatar




External links






  • Official website

  • Grupo Insud

  • Chemo Group

  • Exeltis

  • mAbxience

  • Kramer & Sigman Films

  • Editorial Capital intelectual

  • Pomera Maderas

  • Garruchos

  • Solantu

  • Yacaré Porá

  • Puerto Valle - Hotel de Esteros

  • Mundo Sano

  • Research, Development and Innovation Consortium

  • Argentine Chamber of Biotechnology







1944 births, Argentine businesspeople, Argentine Jews, Argentine people of German-Jewish descent, Argentine pharmacists, Argentine psychiatrists, Argentine scientists, Living people, University of Buenos Aires alumniUncategorized

Popular posts from this blog

Frič See also Navigation menuinternal link

Identify plant with long narrow paired leaves and reddish stems Planned maintenance scheduled April 17/18, 2019 at 00:00UTC (8:00pm US/Eastern) Announcing the arrival of Valued Associate #679: Cesar Manara Unicorn Meta Zoo #1: Why another podcast?What is this plant with long sharp leaves? Is it a weed?What is this 3ft high, stalky plant, with mid sized narrow leaves?What is this young shrub with opposite ovate, crenate leaves and reddish stems?What is this plant with large broad serrated leaves?Identify this upright branching weed with long leaves and reddish stemsPlease help me identify this bulbous plant with long, broad leaves and white flowersWhat is this small annual with narrow gray/green leaves and rust colored daisy-type flowers?What is this chilli plant?Does anyone know what type of chilli plant this is?Help identify this plant

fontconfig warning: “/etc/fonts/fonts.conf”, line 100: unknown “element blank” The 2019 Stack Overflow Developer Survey Results Are In“tar: unrecognized option --warning” during 'apt-get install'How to fix Fontconfig errorHow do I figure out which font file is chosen for a system generic font alias?Why are some apt-get-installed fonts being ignored by fc-list, xfontsel, etc?Reload settings in /etc/fonts/conf.dTaking 30 seconds longer to boot after upgrade from jessie to stretchHow to match multiple font names with a single <match> element?Adding a custom font to fontconfigRemoving fonts from fontconfig <match> resultsBroken fonts after upgrading Firefox ESR to latest Firefox